Detalhe da pesquisa
1.
Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
J Clin Oncol
; 39(29): 3261-3272, 2021 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34156898